Mirae Asset Global Etfs Holdings Ltd. Arvinas, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Arvinas, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 35,161 shares of ARVN stock, worth $909,263. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,161
Previous 26,032
35.07%
Holding current value
$909,263
Previous $692,000
25.14%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARVN
# of Institutions
229Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$181 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$174 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$162 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$99.7 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$72 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.38B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...